33
Participants
Start Date
September 30, 2014
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Oxytocin
"For Phase I, subjects will be randomized to receive either 24IU (6 sprays) of active oxytocin or 6 sprays of placebo (3 sprays per nostril)~For Phase II, subjects will be randomized to receive either 8 IU or 40 IU of oxytocin."
The University of North Carolina at Chapel Hill, Chapel Hill
Collaborators (1)
Duke University
OTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of North Carolina, Chapel Hill
OTHER